Director RSU award: Strata Critical Medical (SRTA) grants 50,234 units
Rhea-AI Filing Summary
WIESENTHAL ROBERT S reported acquisition or exercise transactions in this Form 4 filing.
Strata Critical Medical, Inc. reported that director Robert S. Wiesenthal received a grant of 50,234 Restricted Stock Units (RSUs) of Class A common stock on 2026-07-30. These RSUs will be settled in shares upon vesting, with 100% vesting on the date of the company’s 2027 Annual Meeting of Stockholders. Following this award, Wiesenthal holds 5,325,896 shares of Class A common stock. The award carries a stated price of $0.0000 per share, reflecting a non-cash equity grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 50,234 shares
Net Buy
1 txn
Insider
WIESENTHAL ROBERT S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A common stock, $0.0001 par value per share F1 | 50,234 | $0.00 | $0.00 |
Holdings After Transaction:
Class A common stock, $0.0001 par value per share — 5,325,896 shares (Direct)
Footnotes (1)
- F1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.
Key Figures
RSUs granted: 50,234 shares
Grant price per share: $0.0000
Shares following transaction: 5,325,896 shares
+1 more
4 metrics
RSUs granted
50,234 shares
Restricted Stock Units granted to director on 2026-07-30
Grant price per share
$0.0000
Stated per-share price for the non-cash RSU equity award
Shares following transaction
5,325,896 shares
Total Class A common stock held by Robert S. Wiesenthal after the award
Vesting event
2027 Annual Meeting of Stockholders
100% of the 50,234 RSUs vest on this meeting date
Key Terms
Restricted Stock Units, Class A common stock, par value, Annual Meeting of Stockholders
4 terms
Restricted Stock Units financial
"Represents a grant of Restricted Stock Units ("RSUs"), which will be settled"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A common stock financial
"Class A common stock, $0.0001 par value per share"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
par value financial
"Class A common stock, $0.0001 par value per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
Annual Meeting of Stockholders financial
"100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did SRTA director Robert S. Wiesenthal report?
Director Robert S. Wiesenthal reported receiving a grant of 50,234 Restricted Stock Units (RSUs) of Strata Critical Medical, Inc. Class A common stock. The RSUs are equity awards that will be settled in shares of common stock when they vest in 2027.
When do the 50,234 RSUs granted by SRTA to Robert S. Wiesenthal vest?
All 50,234 RSUs will vest 100% on the date of Strata Critical Medical’s 2027 Annual Meeting of Stockholders. Once vested, the RSUs will be settled in shares of the company’s common stock, increasing his share-based holdings.
Was any cash paid for the SRTA RSU grant to Robert S. Wiesenthal?
No cash was paid for the RSU grant; the transaction shows a price of $0.0000 per share. This indicates the 50,234 RSUs were issued as a non-cash equity award, typical of director or executive compensation arrangements.
Will the SRTA RSUs granted to Robert S. Wiesenthal be settled in stock or cash?
The 50,234 RSUs will be settled in shares of Strata Critical Medical’s common stock upon vesting. The footnote specifies that each Restricted Stock Unit converts into common shares when vesting occurs at the company’s 2027 Annual Meeting of Stockholders.